National Health (Weighted average disclosed price – April 2017 reduction day) Amendment Determination 2017 (No.1) (PB 12 of 2017) (Cth)

PB 12 of 2017

National Health (Weighted average disclosed price – April 2017 reduction day) Amendment Determination 2017 (No.1)

National Health Act 1953

I, LOUISE CLARKE, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:  17  January 2017

LOUISE CLARKE

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1. Name of Determination

(1)     This Determination is the National Health (Weighted average disclosed price – April 2017 reduction day) Amendment Determination 2017 (No.1).

(2)     This Determination may also be cited as PB 12 of 2017.

1. Commencement

This Determination commences on the day after it is registered.

1. Amendments to PB 109 of 2016

Schedule 1 amends the National Health (Weighted average disclosed price – April 2017 reduction day) Determination 2016 (PB 109 of 2016).

Schedule 1       Amendments

[1]     Schedule 1

omit:

470	Iron polymaltose complex	Injection 100 mg (iron) in 2 mL	Injection	Ferrosig	7.53
471	Iron polymaltose complex	Injection 100 mg (iron) in 2 mL	Injection	Ferrum H	7.53

[2]     Schedule 1

omit:

1034 Sorbitol with sodium citrate and sodium lauryl sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 Rectal Micolette 7.28

[3]     Schedule 1

omit:

1135	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursodox GH	116.74
1136	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursofalk	116.74
1137	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursosan	116.74

[4]     Schedule 1

omit:

1153	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	APO-Zoledronic Acid	244.25
1154	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	DBL Zoledronic Acid	244.25
1155	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	Zometa	244.25
1156	Zoledronic acid	Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL	Injection	DBL Zoledronic Acid	244.25
1157	Zoledronic acid	Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL	Injection	Zometa	244.25
1158	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Aclasta	327.01
1159	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Osteovan	327.01
1160	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Ostira	327.01
1161	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Zoledasta	327.01

substitute:

1153	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	APO-Zoledronic Acid	245.33
1154	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	DBL Zoledronic Acid	245.33
1155	Zoledronic acid	Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL	Injection	Zometa	245.33
1156	Zoledronic acid	Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL	Injection	DBL Zoledronic Acid	245.33
1157	Zoledronic acid	Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL	Injection	Zometa	245.33
1158	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Aclasta	328.46
1159	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Osteovan	328.46
1160	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Ostira	328.46
1161	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Zoledasta	328.46

[4]     Schedule 2

after:

1032 Irbesartan with hydrochlorothiazide Tablet 300 mg-25 mg Oral Terry White Chemists Irbesartan HCTZ 4.54

insert:

1032A	Iron polymaltose complex	Injection 100 mg (iron) in 2 mL	Injection	Ferrosig	11.63
1032B	Iron polymaltose complex	Injection 100 mg (iron) in 2 mL	Injection	Ferrum H	11.63

[5]     Schedule 2

after:

2116 Somatropin Solution for injection 6 mg (18 i.u.) in 1.03 mL cartridge (with preservative) Injection Saizen 249.48

insert:

2116A Sorbitol with sodium citrate and sodium lauryl sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 Rectal Micolette 8.05

[6]     Schedule 2

after:

2302 Tropisetron I.V. injection 5 mg (as hydrochloride) in 5 mL Injection Tropisetron-AFT 4.74

insert:

2302A	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursodox GH	132.03
2302B	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursofalk	132.03
2302C	Ursodeoxycholic acid	Capsule 250 mg	Oral	Ursosan	132.03